ARCHIVES

Lasofoxifene Reduced Breast Cancer Risk In Postmenopausal Osteoporotic Women

This article is from The Cancer Letter archive.

Vol. 33 No. 11 | November 26, 2010

Download PDF Visit The Full Archive

Related Articles

New CCOP RFA To Encourage Cancer Control Research; Larger But Fewer Awards Are Likely

May 9, 1986

FDA Approves Evista for Breast Cancer Risk Reduction.

September 14, 2007

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

Pharmacia Says SU5416 Doesn’t Benefit Colorectal Cancer Patients, Closes Trial.

March 1, 2002

NIH Lifts Patient Limit On Gene Modified TIL Study; 6 Treated So Far

April 13, 1990

Senate Subcommittee Adds $98 Million to NCI’s FY 1984 Budget, Assuring Substantial Increase

September 30, 1983